Nigerian pharmaceutical firm, MeCure Industries Plc has launched a N10 billion, 269-day Series 6 commercial paper (CP), offering investors an effective annual yield of 21 percent, according to market watchers, who say this is a signal of rising corporate appetite for short-term funding amid strong e
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
